Where is MiroBio headquartered?

MiroBio is located in Oxford, england.

Who invested in MiroBio?

MiroBio has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for MiroBio?

MiroBio closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

mirobio.com

MiroBio

MiroBio is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of auto-immune diseases.

Business Model:

Revenue: $2.2M

Employees: 11-50

MiroBio was acquired by Gilead Sciences.
The acquisition happend on 2022-08-04.
Details of the transaction were not public

Acquirer

Gilead Sciences

General Information

Geographic Data

Address: Heatley Road

City: Oxford

State: england

Zip: OX4 4GE

Country: GB

Financial Info

Stage:

series b

Raised Last:

$97M

Raised Total:

$130M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

MiroBio is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of auto-immune diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2019	Series A		$33M	Oxford Sciences Innovation Samsara Biocapital Advent Life Sciences SR One
6/2022	Series B		$0	Advent Life Sciences Medicxi Monograph Capital OrbiMed Oxford Science Enterprises Samsara BioCapital SR One Advent Life Sciences Medicxi Monograph Capital OrbiMed Oxford Science Enterprises Samsara BioCapital SR One
10/2019	Series A	4	$33.2M	SR One Advent Life Sciences Samsara BioCapital Oxford Science Enterprises Samsara BioCapital SR One Advent Life Sciences Samsara BioCapital Oxford Science Enterprises Samsara BioCapital
6/2022	Series B		$97M	Medicxi OrbiMed Monograph Capital Oxford Science Enterprises Samsara BioCapital SR One Capital Management Advent Life Sciences
6/2022	Series B	7	$97M	Advent Life Sciences Medicxi Monograph Capital OrbiMed Oxford Science Enterprises Samsara BioCapital SR One Advent Life Sciences Medicxi Monograph Capital OrbiMed Oxford Science Enterprises Samsara BioCapital SR One

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details